Duplicate Subjects In Your Clinical Trials Result In Safety & Data Quality Issues
To maintain data integrity and safety, it is necessary to highlight and detect duplicate subjects in your clinical trials proactively. This is true for nearly all therapeutic indications and all phases of clinical trials research. Duplicate enrollment (over enrollment) is NOT just a healthy volunteer phase 1 issue. The global research subject database registry VCT data over the …